Enrichment of T-cell markers (CD3, CD4), macrophage markers (CD68, CD168), immune checkpoints (CD27 and V-domain Ig suppressor of T-cell activation [VISTA]), CD44 and CD45 were seen in the stroma relative to the tumour. This evidence concerns the gene CD27 and neoplasm.